Rebamipide

Rebamipide

SCHEMBL296716

NCCCC[C@H](N)C(=O)O.O=C(NC(Cc1cc(=O)[nH]c2ccccc12)C(=O)O)c1ccc(Cl)cc1

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Rebamipide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
UBASH3B Q8TF42 1/20 0.78
ERAP2 Q6P179 8/20 0.48
LNPEP Q9UIQ6 7/20 0.48
ERAP1 Q9NZ08 6/20 0.48
PPARG P37231 1/20 0.46
F11 P03951 1/20 0.46
ITGB2 P05107 3/20 0.45
ICAM1 P05362 3/20 0.45
ITGAL P20701 3/20 0.45
TACR1 P25103 1/20 0.43
CCKBR P32239 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rebamipide SCHEMBL16667091 1.00 UBASH3B (0.78) UBASH3BERAP2LNPEPERAP1PPARG
Rebamipide SCHEMBL2866138 0.90 UBASH3B (0.92) UBASH3BERAP2PPARGF11ITGB2
SCHEMBL296717 0.89 UBASH3B (0.66) UBASH3BERAP2LNPEPERAP1PPARG
Rebamipide SCHEMBL23346201 0.88 UBASH3B (1.00) UBASH3BERAP2PPARGF11ITGB2
Rebamipide SCHEMBL5794018 0.88 UBASH3B (1.00) UBASH3BERAP2PPARGF11ITGB2
Rebamipide SCHEMBL21623658 0.88 UBASH3B (1.00) UBASH3BERAP2PPARGF11ITGB2
Rebamipide SCHEMBL221527 0.88 UBASH3B (1.00) UBASH3BERAP2PPARGF11ITGB2
Rebamipide SCHEMBL29560992 0.88 UBASH3B (1.00) UBASH3BERAP2PPARGF11ITGB2
Rebamipide SCHEMBL297016 0.88 UBASH3B (0.72) UBASH3BERAP2LNPEPERAP1PPARG
Rebamipide SCHEMBL9114879 0.87 UBASH3B (0.98) UBASH3BERAP2PPARGF11ITGB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2253619-B1 Amine salt of carbostyril derivative OTSUKA PHARMA CO LTD (JP) 2012-03-14 EP disclosed
EP-2253619-A1 Amine salt of carbostyril derivative Otsuka Pharmaceutical Co., Ltd. (JP) 2010-11-24 EP disclosed